Premier Biomedical,
Premier Biomedical, Inc. President and CEO William Hartman Discusses Company Updates Since July 2018 and Their 250:1-Split with Everett Jolly on Uptick Newswire’s “Stock Day” Podcast
August 27, 2018 08:30 ET | Premier Biomedical, Inc.
PHOENIX, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTCQB:BIEI) (the “Company”), announced President and CEO William A. Hartman’s interview on Uptick Newswire’s “Stock Day” Podcast....
Diamond Equity Research Initiates Coverage on Genprex Inc. (NASDAQ: GNPX) with a Valuation of $13 Per Share
July 02, 2018 09:30 ET | Genprex Inc Registered Shs
NEW YORK, July 02, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – Diamond Equity Research, a leading equity research and corporate access firm with a focus on small capitalization public companies has...
Logo-BCC-Research.jpg
Breast Cancer Companion Diagnostics to Surpass $1B by 2022
May 30, 2018 16:45 ET | BCC Research
WELLESLEY, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- The need for safer, more efficacious drugs and better diagnostic tools is driving growth in the global market for breast cancer diagnostics and...
Reflexion-3000px-Hi-Res.png
RefleXion Medical Raises $100 Million Series C to Commercialize Revolutionary Cancer Treatment
April 04, 2018 03:01 ET | RefleXion Medical
HAYWARD, Calif., April 04, 2018 (GLOBE NEWSWIRE) -- RefleXion Medical, a medical technology company developing the first and only biology-guided radiotherapy system (BgRT) for targeted cancer...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech Reaches Preliminary Agreement for Distribution of CanChew and MedChew Products Throughout South Korea
April 03, 2018 09:00 ET | AXIM BIOTECHNOLOGIES, INC
NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTCQB:AXIM), a world leader in cannabinoid research and development, today announced that it has...
PRPO logo.png
Precipio Launches Unique Lung Cancer Monitoring Test for Therapy Resistance
February 15, 2018 08:38 ET | Precipio, Inc.
NEW HAVEN, Conn., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO) announced today its launch of the first lung cancer treatment resistance panel specifically for the critical...
PRPO logo.png
Precipio Announces Q4 2017 Revenue at 350% of Previous Quarter
February 09, 2018 09:00 ET | Precipio, Inc.
NEW HAVEN, Conn., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces preliminary, unaudited revenues for the 4th quarter of 2017 of approximately...
energias.jpg
Global Anticancer Drug Market- Providing Targeted Treatment Solutions to Cancer Patients Using Nano-Technology Enhancing the Way to Cure the Disease, Reach USD 145.2 Billion By 2023: Energias Market Research Pvt. Ltd.
February 08, 2018 06:32 ET | Energias Market Research
NEW YORK, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Global Anticancer Drug market size is expected to reach USD 145.2 Billion in 2023, at a CAGR of 6.7% from 2017 to 2023. The growth of the...
PRPO logo.png
Precipio Enters Japanese Liquid Biopsy Market with First Hospital Sale
February 06, 2018 08:37 ET | Precipio, Inc.
NEW HAVEN, Conn., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces its entry into the Japanese market with a first order of its ICE-COLD PCR™...
Cancer Treatment Cen
Cancer Treatment Centers of America® at Midwestern Regional Medical Center Opens Outpatient Care Center in Chicago Chicago, Ill., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center (Midwestern) is proud to announce the grand opening of its first...